Stocklytics Platform
Asset logo for symbol ARYD
ARYA Sciences Acquisition Corp IV
ARYD25
$2.890.00%$0.00
Penny Stock
Asset logo for symbol ARYD
ARYD25

$2.89

0.00%

Income Statement (ARYD)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
EBIT-$1.22M-$5.49M-$1.91M-$157.70K-$271.13K
EBITDA-$611.74K-$2.74M-$959.67K-$78.85K-$1.45M
gross Profit-----
NET Income-$245.84K-$2.22M-$455.07K$381.51K-$3.14M
total Revenue$0.00$0.00$0.00$0.00$0.00

Balance Sheet (ARYD)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
cash Equivalents-----
net Debt$3.05M$2.15M$1.69M$1.24M$28.95K
stockholders Equity$22.49M$25.68M$27.90M$28.35M$142.88M
total Assets$37.26M$40.65M$39.80M$38.98M$151.77M
total Debt$3.14M$2.17M$1.70M$1.26M$120.00K
total Liabilities$14.76M$14.96M$11.89M$10.62M$8.88M

Cash Flow (ARYD)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
financing Cash Flow-$3.38M$470.00K$445.00K$540.00K$120.00K
free Cash Flow-$511.68K-$43.61K-$29.22K-$441.98K-$52.08K
investing Cash Flow----$140.00K$114.65M
operating Cash Flow-$511.68K-$43.61K-$29.22K-$441.98K-$52.08K

ARYA Sciences Acquisition Corp IV (ARYD) Financials

ARYA Sciences Acquisition Corp IV (ARYD) is a company that specializes in acquiring and merging with businesses in the healthcare and life sciences industries. As a special purpose acquisition company (SPAC), ARYD aims to provide opportunities for investors to benefit from the growth and development of innovative healthcare companies. In order to assess the financial performance of ARYD, it is important to examine key aspects such as its income statement, EBIT (earnings before interest and taxes), EBITDA (earnings before interest, taxes, depreciation, and amortization), gross profit, net income from stockholders, total revenue, balance sheet, cash equivalents, net debt, stockholders equity, total assets, total debt, total liabilities, cash flow, financing cash flow, free cash flow, investing cash flow, and operating cash flow.
add ARYA Sciences Acquisition Corp IV to watchlist

Keep an eye on ARYA Sciences Acquisition Corp IV

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level